1.Prognostic significance of NAD (P) H-quinone oxidoreductase 1 overex-pression in ovarian mucinous cystadenocarcinoma
Ming XU ; Yang YANG ; Shuanlong CHE ; Yingshi PIAO ; Zhenhua LIN ; Liyan CHEN
Chinese Journal of Pathophysiology 2016;32(8):1461-1465
AIM: To investigate the significance of NAD (P)H-quinone oxidoreductase 1 (NQO1) protein overexpression for prognostic evaluation of ovarian mucinous cystadenocarcinoma .METHODS:NQO1 protein was detected in 162 cases of ovarian mucinous cystadenocarcinoma , 35 cases of ovarian mucinous cystadenoma and 29 samples of normal ovarian epithelial tissues by the method of EnVision immunohistochemical staining .The correlation between high expression of NQO1 protein and clinicopathological features of ovarian mucinous cystadenocarcinoma was also evaluated .Overall sur-vival and disease-free survival rates of ovarian mucinous cystadenocarcinoma patients were calculated by Kaplan -Meier method.RESULTS:The positive rate and strongly positive rate of NQO 1 protein were 85.8%and 64.2%in ovarian mu-cinous cystadenocarcinoma , respectively , which are significantly higher than those in ovarian mucinous cystadenoma , and normal ovarian epithelial tissues ( P <0.01 ) .NQO1 expression was significantly correlated with the histological grade (P<0.05) and clinical stage (P<0.01) of ovarian mucinous cystadenocarcinoma .Kaplan-Meier survival analysis showed that the overall survival rate and disease-free survival rate were significantly higher in ovarian mucinous cystadenocarcinoma patients with high NQO1 expression than those with low NQO1 expression (P<0.01).CONCLUSION:NQO1 expression is closely correlated with the progression and prognosis of the patients with ovarian mucinous cystadenocarcinoma .High ex-pression of NQO1 protein may be used as an important indicator for the patients with poor prognosis of ovarian mucinous cystadenocarcinoma .
2.Effect of GDF11 on expansion of CD8 +memory stem T cells
Xingru MA ; Yingshi CHEN ; Yingtong LIN ; Xu ZHANG ; Haihua LUO ; Chao LIU ; Ting PAN
Chinese Journal of Pathophysiology 2016;32(4):762-768
AIM:To investigate the effect of growth differentiation factor 11 ( GDF11 ) on the expansion of CD8 +memory stem T cells ( Tscm) and to further improve the effect of adoptive immunotherapy.METHODS:Healthy human peripheral blood mononuclear cells ( PBMCs) were isolated by density gradient centrifugation at first.Among the i-solated PBMCs, CD8 +T cells were further purified with MACS microbeads.The CD8 +T cells were then randomly divided into experimental groups and control group.The same volume of different concentrations of GDF11 were added into the ex-perimental groups, and the same volume of PBS solution was added into the control group.Finally, the expansion of Tscm in experimental groups and control group was measured by flow cytometry at several time points.RESULTS:GDF11 sig-nificantly increased the number of Tscm in CD8 +T cells in vitro expansion and also dramatically increased the ratio of Tscm in CD8 +T cells.Furthermore, 400 μg/L GDF11 treatment for 3 weeks was the optimal condition to induce CD8 +Tscm. CONCLUSION:GDF11 effectively increases the number and ratio of Tscm in the CD8 +T cells in cell culture growth, thereby creating a new strategy to further improve the efficiency of adoptive immunotherapy.
3.High resolution reconstruction for optimization of imaging quality of GE Discovery CT 750 HD
Mailin CHEN ; Xiaoting LI ; Yingshi SUN
Chinese Journal of Interventional Imaging and Therapy 2018;15(2):104-107
Objective To explore the value of high resolution reconstruction for optimization of imaging quality of GE Discovery CT 750 HD based on phantom pilot.Methods CT scanning with large (50 cm) and small (32 cm) scanning field of view (SFOV) was performed for a Catphan 500 phantom with or without high resolution on GE Discovery CT 750 HD.All raw data acquired by volumetric CT scan were reconstructed as the same size of a small DFOV (25 cm) with STAND algorithm.Then the images were divided into four groups,including large SFOV without high resolution (group A),large SFOV with high resolution (group B),small SFOV without high resolution (group C) and small SFOV with high resolution (group D).The spatial-resolution (SR),density-resolution (DR),noise (N),CNR,SNR and CT dose index volumes (CTDI) were measured and compared among 4 groups.Results The overall differences of SR,DR,N,CNR,SNR and CTDI were statistically significant among four groups (all P<0.05).Compared with group A,the average N increased in group C (P<0.01),SR increased in group B and the average CNR and SNR decreased in group D,while N increased in group D (all P<0.01).Conclusion Large SFOV combined with high resolution reconstruction may ensure CNR and SNR,and improve SR.
4.Multidetector CT for Restaging Locally Advanced Esophageal Squamous Cell Carcinoma and Assessing Therapeutic Response to Neoadjuvant Chemotherapy.
Yanjie SHI ; Ying CHEN ; Xiaoting LI ; Zhilong WANG ; Yingshi SUN
Acta Academiae Medicinae Sinicae 2017;39(1):133-139
Objective To assess the diagnostic accuracy of multidetector CT (MDCT) for restaging of patients with esophageal squamous cell carcinoma (SCC) after neoadjuvant chemotherapy and determine the feasibility of CT for assessing the treatment response and evaluating the prognosis. Methods Totally 135 patients with esophageal SCC who had received neoadjuvant treatment and surgery in Beijing Cancer Hospital from September 2005 to December 2011 were enrolled in this study. TN staging was performed using CT for lesions before and after neoadjuvant treatment by two radiologists,and the tumor regression grade (TRG) and pathological TRG were also assessed. Based on preoperative CT TN restaging results,the patients were defined as responders with TNafter therapy,non-responders with T3-4N+,and patients with undefined response (TN0 or TNN). Results The accuracy of T and N restaging using CT was 50%,54% (κ=0.718,P <0.001) and 59%,56% (κ=0.753,P <0.001) by two radiologists,respectively. TRG from CT was predicted correctly in 27% of patients. Pathological TRG was an accurate predictor of survival (χ=8.13,P=0.04). There was no significant trend toward better survival for lower CT TRG (χ=1.17,P=0.286). Among 135 patients with esophageal cancer,19 patients(14.07%) were responders ,46 patients(34.07%) were non-responders,and 70 patients (50.37%)were patients with undefined response . The overall survival rates of responders,non-responders and patients with undefined response were 71.5%,47.3%,and 18.5%,respectively. The overall survival of responders was better than that of patients with undefined response (χ=1.518,P=0.63) and non-responders(χ=12.04,P=0.0016),but the overall survival of patients with undefined response was better than that of non-responders (χ=14.468,P=0.0003). Conclusion sMDCT restaging after neoadjuvant treatment can not accurately predict pathological stage in esophageal SCC. The CT T and N restaging has certain clinical value in assessing the response to neoadjuvant chemotherapy in patients with esophageal cancer and predicting the prognosis.
Carcinoma, Squamous Cell
;
diagnostic imaging
;
drug therapy
;
Esophageal Neoplasms
;
diagnostic imaging
;
drug therapy
;
Humans
;
Neoadjuvant Therapy
;
Neoplasm Staging
;
Prognosis
;
Survival Rate
;
Tomography, X-Ray Computed
5.Long-term prognostic analysis on complete/near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy.
Lin WANG ; Shijie LI ; Xiaoyan ZHANG ; Tingting SUN ; Changzheng DU ; Nan CHEN ; Yifan PENG ; Yunfeng YAO ; Tiancheng ZHAN ; Jun ZHAO ; Yong CAI ; Yongheng LI ; Weihu WANG ; Zhongwu LI ; Yingshi SUN ; Jiafu JI ; Aiwen WU
Chinese Journal of Gastrointestinal Surgery 2018;21(11):1240-1248
OBJECTIVE:
To investigate the long-term outcome of organ preservation with local excision or "watch and wait" strategy for mid-low rectal cancer patients evaluated as clinical complete remission (cCR) or near-cCR following neoadjuvant chemoradiotherapy (NCRT).
METHODS:
Clinical data of 62 mid-low rectal cancer patients evaluated as cCR/near-cCR after NCRT undergoing organ preservation surgery with local excision or receiving "watch and wait" strategy at Department of Gastrointestinal Surgery, Peking University Cancer Hospital and Institute from March 2011 to August 2017 were retrospectively analyzed. According to the approximate 1:2 pairing, 123 patients who underwent radical resection with complete pathological remission(ypCR) after neoadjuvant chemotherapy during the same period were selected for prognosis comparison. The primary endpoint of the study was 3-year non-regrowth disease-free survival (NR-DFS) and tumor specific survival (CSS). Survival analysis was performed using the Kaplan-Meier curve (Log-rank method). The secondary endpoint of the study was 3-year organ preservation and sphincter preservation.
RESULTS:
The retrospective study included 38 male and 24 female patients. The median age was 60 (31-79) years and the median distance from tumor to anal verge was 4(1-8) cm. The ratio of cCR and near-cCR was 79.0%(49/62) and 21.0%(13/62) respectively. Local regrowth rate was 24.2%(15/62). Of 15 with tumor regrowth, 9 patients received salvage radical rectal resection and no local recurrence was found during follow-up; 4 patients received salvage local excision among whom one patient had a local recurrence occurred patient; 2 patients refused further surgery. The overall metastasis rate was 8.1%(5/62), including resectable metastasis(4.8%,3/62) and unresectable metastasis (3.2%,2/62). The valid 3-year organ preservation rate and sphincter preservation rate were 85.5%(53/62) and 95.2%(59/62) respectively. The median follow-up was 36.2(8.6-89.0) months. The 3-year NR-DFS of patients with cCR and near-cCR was 88.6% and 83.1% respectively, which was not significantly different to that of patients with ypCR (94.7%, P=0.217). The 3-year CSS of patients with cCR and near-cCR was both 100%, which was not significantly different to that of patients with ypCR(93.4%, P=0.186).
CONCLUSIONS
Mid-low rectal cancer patients with cCR or near-cCR after NCRT undergoing organ preservation with local excision or receiving "watch and wait" strategy have good long-term prognosis with low rates of local tumor regrowth and distant metastasis, which is similar to those with ypCR after radical surgery. This treatment mode may be used as an option for organ preservation in mid-low rectal cancer patients with good tumor remission after NCRT.
Adult
;
Aged
;
Chemoradiotherapy
;
Female
;
Humans
;
Male
;
Middle Aged
;
Neoadjuvant Therapy
;
Neoplasm Recurrence, Local
;
Neoplasm Staging
;
Prognosis
;
Rectal Neoplasms
;
diagnosis
;
therapy
;
Retrospective Studies
;
Treatment Outcome
;
Watchful Waiting